Rezolute, Inc.
Status: Publicly traded
Direct answer
Rezolute, Inc. is publicly traded on NASDAQ under the ticker RZLT.
Rezolute, Inc. is a clinical-stage biopharmaceutical company focused on developing groundbreaking therapies for metabolic conditions marked by persistent glucose imbalances, primarily serving the United States market. Its flagship product candidate, RZ358, a human monoclonal antibody, is currently progressing through Phase 2b clinical trials as a potential treatment for congenital hyperinsulinism, an exceptionally...
Can you invest in Rezolute, Inc.?
Yes. Rezolute, Inc. is publicly traded on NASDAQ under the ticker RZLT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Rezolute, Inc.
Detailed equity research is provided by MarketSnap.